Royal Bank of Canada
CAI

Royal Bank of Canada’s Caris Life Sciences CAI Stock Holding History

Royal Bank of Canada’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$333K Buy
18,651
+9,407
+102% +$206K ﹤0.01% 4408
2025
Q4 		$250K Buy
9,244
+4,953
+115% +$139K ﹤0.01% 4629
2025
Q3 		$130K Buy
4,291
+3,470
+423% +$111K ﹤0.01% 5358
2025
Q2 		$22K Buy
+821
New +$22.1K ﹤0.01% 6235

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Royal Bank of Canada's CAI Position: Q1 2026 in Review

Royal Bank of Canada increased its Caris Life Sciences (CAI) stake by 102% in Q1 2026, buying an estimated $206K and bringing the position to 18,651 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #4408.

Royal Bank of Canada first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Royal Bank of Canada held 18,651 shares of Caris Life Sciences worth $333K as of Q1 2026.
  • Royal Bank of Canada bought 9,407 Caris Life Sciences shares in Q1 2026, an estimated $206K.
  • Caris Life Sciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4408 holding.
  • Royal Bank of Canada first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.